Study: Nalls, 2014

Population Ethnicity Diagnosis Source # Cases (% women) # Controls (% women) AAO (sd) AAO range AAE (sd) AAE range Ctrl age (sd) Ctrl age range # Polymorphisms
Germany (NeuroX) C not provided CL 1,044 871 - - - - - - 27

Polymorphisms in this population [-]

Polymorphism Location (hg19) Gene Allele contrast Ethnicity # Studies # Samples 1000G CEU 1000G CHB+JPT Meta OR (95%CI) I2 (95%CI) Meta P-value
rs823118 chr1:205723572 NUCKS1 [+4168bp] C vs. T All: C 21 120,238 0.45 (C) 0.417 (T) 0.89 (0.87-0.92) 41 (0-65) 1.96e-16
rs10797576 chr1:232664611 SIPA1L2 T vs. C All: C 21 120,238 0.092 (T) 0.092 (T) 1.13 (1.09-1.18) 0 (0-41) 1.76e-10
rs6430538 chr2:135539967 intergenic T vs. C All: C 21 120,238 0.408 (T) 0.025 (C) 0.88 (0.85-0.90) 0 (0-45) 3.35e-19
rs1955337 chr2:169129145 STK39 [+24494bp] T vs. G All: C 21 120,238 0.083 (T) 0.317 (T) 1.21 (1.16-1.26) 17 (0-51) 1.67e-20
rs62267708 chr3:87489314 intergenic T vs. C All: C 14 39,208 0.05 (T) - 1.15 (1.03-1.29) 88 (82-92) 0.016
rs34016896 chr3:160992864 NMD3 [+21544bp] T vs. C All: C 21 120,238 0.333 (T) 0.433 (C) 1.06 (1.03-1.09) 33 (0-61) 4.69e-05
rs12637471 chr3:182762437 MCCC1 A vs. G All: C 21 120,238 0.242 (A) 0.417 (G) 0.84 (0.81-0.87) 35 (0-62) 5.38e-22
rs34311866 chr4:951947 TMEM175 C vs. T All: C 21 120,238 0.15 (C) 0.075 (C) 1.26 (1.22-1.31) 52 (21-71) 6.00e-41
rs11724635 chr4:15737101 BST1 C vs. A All: C 21 120,238 0.433 (C) 0.458 (A) 0.89 (0.87-0.91) 8 (0-42) 4.26e-17
rs6812193 chr4:77198986 FAM47E T vs. C All: C 21 120,238 0.392 (T) 0.092 (T) 0.91 (0.88-0.93) 36 (0-62) 1.85e-11
rs356182 chr4:90626111 SNCA [-19139bp] G vs. A All: C 21 120,238 0.417 (G) 0.375 (A) 1.34 (1.30-1.38) 50 (17-70) 1.85e-82
rs199347 chr7:23293746 GPNMB G vs. A All: C 21 120,238 0.392 (G) 0.325 (G) 0.90 (0.87-0.92) 11 (0-46) 5.62e-14
rs591323 chr8:16697091 intergenic A vs. G All: C 21 120,238 0.325 (A) 0.383 (A) 0.91 (0.89-0.94) 0 (0-43) 3.17e-08
rs118117788 chr10:121710488 MIR4682 [-7537bp] T vs. C All: C 18 112,572 0.025 (T) - 1.58 (1.37-1.82) 0 (0-48) 5.40e-10
rs12283611 chr11:83487277 DLG2 A vs. C All: C 21 120,238 0.35 (A) 0.25 (A) 0.93 (0.90-0.96) 0 (0-22) 3.02e-07
rs329648 chr11:133765367 MIR4697 [-3032bp] T vs. C All: C 21 120,238 0.333 (T) 0.267 (T) 1.11 (1.07-1.14) 0 (0-47) 8.05e-12
rs76904798 chr12:40614434 LRRK2 T vs. C All: C 21 120,238 0.158 (T) - 1.16 (1.11-1.20) 0 (0-47) 4.86e-14
rs11060180 chr12:123303586 CCDC62 G vs. A All: C 17 105,818 0.483 (G) 0.208 (G) 0.91 (0.88-0.93) 21 (0-56) 3.08e-11
rs11158026 chr14:55348869 GCH1 T vs. C All: C 21 120,238 0.367 (T) 0.417 (C) 0.91 (0.88-0.94) 40 (0-64) 2.88e-10
rs2414739 chr15:61994134 intergenic G vs. A All: C 21 120,238 0.283 (G) 0.183 (G) 0.90 (0.87-0.92) 19 (0-52) 3.59e-12
rs14235 chr16:31121793 BCKDK A vs. G All: C 21 120,238 0.45 (A) 0.092 (G) 1.10 (1.07-1.14) 31 (0-59) 3.63e-12
rs11868035 chr17:17715101 SREBF1 A vs. G All: C 21 120,238 0.258 (A) 0.142 (G) 0.94 (0.91-0.97) 40 (0-65) 2.43e-05
rs17649553 chr17:43994648 MAPT T vs. C All: C 20 114,483 0.217 (T) - 0.77 (0.75-0.80) 0 (0-37) 6.11e-49
rs12456492 chr18:40673380 RIT2 G vs. A All: C 21 120,238 0.375 (G) 0.4 (G) 1.10 (1.07-1.14) 17 (0-51) 2.15e-11
rs10402629 chr19:2324458 LSM7 G vs. A All: C 20 114,483 0.242 (G) 0.45 (G) 1.07 (1.03-1.11) 47 (10-68) 1.20e-04
rs55785911 chr20:3153503 UBOX5 [+12661bp] A vs. G All: C 21 120,238 0.417 (A) 0.392 (G) 0.91 (0.88-0.94) 29 (0-58) 3.30e-10
rs71628662 chr1:155359992 ASH1L T vs. C All: C 18 110,323 - - 0.52 (0.46-0.58) 0 (-) 6.86e-28